Zinc-dependent thymic nonapeptide — only thymic hormone requiring a cofactor for activity. Studied for immune restoration, anti-inflammatory effects, and has demonstrated analgesic properties in pain models. Declines with thymic involution.
Thymulin (FTS — facteur thymique serique) is a nine-amino-acid peptide produced exclusively by the thymus gland. It requires zinc to be biologically active — without zinc it exists in an inactive form. It has been studied for immune regulation, pain modulation, anti-inflammatory effects, and potential anti-aging properties. Research interest extends from immunology to its unusual role in regulating both immune and nervous system pathways.
Immune Regulation Research
Thymulin is involved in the maturation and function of T-cells. It is measurable in blood and declines with age and with zinc deficiency. Research has examined its role as a marker of thymic function and as a potential immunomodulatory treatment in aging and immune decline.
Pain Research
More recent research has discovered that Thymulin has significant anti-pain effects in animal models. A modified form that is zinc-independent has been studied for neuropathic pain, inflammatory pain, and migraine models, showing strong analgesic effects through mechanisms involving microglial regulation in the brain.
Anti-Inflammatory Research
Animal studies show Thymulin reduces neuroinflammation by modulating microglia — the immune cells of the brain — and reducing pro-inflammatory cytokine production. This neuroinflammation research is distinct from its classical immune function role and represents a newer area of interest.
Declines with age and zinc deficiency — measurable marker of thymic function.
Requires zinc for biological activity in its natural form.
Animal studies show strong anti-pain and anti-inflammatory effects.
Zinc-independent modified forms are being developed for pain research applications.
Human clinical trial data are limited.
Thymulin human clinical trial data are sparse. Most of the pain and neuroinflammation research is preclinical. The zinc-dependency of natural thymulin adds complexity to its use. It is not FDA-approved. The decline of thymulin with age makes it an interesting biological marker, but whether supplementing it produces meaningful benefits in humans has not been confirmed in clinical trials.
Thymulin is produced by specialized cells in the thymus and is released into the bloodstream where it helps T-cells mature and function normally. It can only bind to its receptors when it is carrying a zinc ion — without zinc, the peptide folds differently and cannot activate its target. This zinc-dependency means that zinc deficiency — which is common in elderly people — can reduce effective thymulin activity even if production levels are normal. More recently, researchers discovered that thymulin also interacts with pain and inflammation pathways in the nervous system, particularly by regulating microglia and cytokine production in the brain in ways that reduce pain signaling.
Thymulin has been used in research studies without significant adverse effects reported. The requirement for zinc and the small human evidence base mean that its safety profile is not comprehensively established by clinical trials. It is not FDA-approved. Research use of natural or modified thymulin forms should be accompanied by appropriate quality controls on purity and sterility.
Preliminary
Most evidence comes from preclinical studies and case reports. Human data is limited and more research is needed.
Published Research Ranges
Research doses: 10ng–10mcg in animal models; human dosing not well established
Research Context Only: These are ranges reported in published scientific studies for educational reference. They are not dosing recommendations. This is not medical advice. Always consult a qualified healthcare professional.
Sources listed here are from the platform research library. All links open the original publication. No citations are generated by AI.
Thymulin (Serum Thymic Factor) and Immune Function: Zinc-Dependent Hormone
Proceedings of the National Academy of Sciences • 1982
• DOI: 10.1073/pnas.79.17.5370
Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common Colds
Perspective: Role of Micronutrients and Omega-3 Long-Chain Polyunsaturated Fatty Acids for Immune Outcomes of Relevance to Infections in Older Adults-A Narrative Review and Call for Action
Research Education Only: This profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions.
We use cookies to enhance your research experience and analyze platform usage. By continuing, you agree to our Cookie Policy.